Nymox Pharmaceutical Corporation (NYMX): Price and Financial Metrics
NYMX Price/Volume Stats
| Current price | $0.20 | 52-week high | $0.74 |
| Prev. close | $0.25 | 52-week low | $0.17 |
| Day low | $0.18 | Volume | 932,700 |
| Day high | $0.22 | Avg. volume | 94,622 |
| 50-day MA | $0.39 | Dividend yield | N/A |
| 200-day MA | $0.38 | Market Cap | 18.10M |
NYMX Stock Price Chart Interactive Chart >
Nymox Pharmaceutical Corporation (NYMX) Company Bio
Nymox Pharmaceutical Corporation engages in the research and development of drugs for the aging population. It markets NicAlert and TobacAlert test strips that use urine or saliva to detect use of tobacco products. The company also offers AlzheimAlert, a proprietary urine assay that aids physicians in the diagnosis of Alzheimers disease. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which is in Phase III clinical trials for the treatment of enlarged prostate or benign prostatic hyperplasia, as well as is in Phase II clinical trial for low grade localized prostate cancer. The company was founded in 1989 and is based in Nassau, The Bahamas.
NYMX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -86.30% |
| 5-year | -89.19% |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | -75.13% |
| 2021 | -47.58% |
| 2020 | 12.73% |
| 2019 | 67.94% |
Continue Researching NYMX
Here are a few links from around the web to help you further your research on Nymox Pharmaceutical Corp's stock as an investment opportunity:Nymox Pharmaceutical Corp (NYMX) Stock Price | Nasdaq
Nymox Pharmaceutical Corp (NYMX) Stock Quote, History and News - Yahoo Finance
Nymox Pharmaceutical Corp (NYMX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...